Ken Griffin Liva Nova PLC Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Liva Nova PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 59,500 shares of LIVN stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,500

Previous 15,600 281.41%

Holding current value

$2.92 Million

Previous $872,000 273.97%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.76 - $64.15 $5.85 Million - $7.25 Million	113,081 Added 7.79%	1,564,605 $85.8 Million
Q1 2024 May 15, 2024	BUY	$48.6 - $57.12 $14.6 Million - $17.2 Million	300,411 Added 26.1%	1,451,524 $81.2 Million
Q4 2023 Feb 14, 2024	BUY	$43.45 - $53.66 $21 Million - $25.9 Million	482,593 Added 72.19%	1,151,113 $59.6 Million
Q3 2023 Nov 14, 2023	BUY	$50.12 - $58.87 $22.3 Million - $26.1 Million	444,165 Added 197.97%	668,520 $35.4 Million
Q2 2023 Aug 14, 2023	SELL	$42.28 - $51.43 $11.5 Million - $14 Million	-272,196 Reduced 54.82%	224,355 $11.5 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $12.1 Million - $17.2 Million	296,207 Added 147.85%	496,551 $21.6 Million
Q4 2022 Feb 14, 2023	BUY	$43.88 - $56.16 $2.54 Million - $3.25 Million	57,901 Added 40.65%	200,344 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$48.37 - $66.5 $5.04 Million - $6.93 Million	104,197 Added 272.44%	142,443 $7.23 Million
Q2 2022 Aug 15, 2022	SELL	$57.25 - $86.63 $9.98 Million - $15.1 Million	-174,266 Reduced 82.0%	38,246 $2.39 Million
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $12.6 Million - $15.4 Million	177,545 Added 507.75%	212,512 $17.4 Million
Q4 2021 Feb 14, 2022	SELL	$76.72 - $92.68 $6.06 Million - $7.32 Million	-79,021 Reduced 69.32%	34,967 $3.06 Million
Q3 2021 Nov 15, 2021	BUY	$76.02 - $88.62 $6.12 Million - $7.14 Million	80,568 Added 241.08%	113,988 $9.03 Million
Q2 2021 Aug 16, 2021	SELL	$73.44 - $87.01 $327,762 - $388,325	-4,463 Reduced 11.78%	33,420 $2.81 Million
Q1 2021 May 17, 2021	SELL	$62.9 - $82.41 $4.62 Million - $6.05 Million	-73,452 Reduced 65.97%	37,883 $2.79 Million
Q4 2020 Feb 16, 2021	SELL	$46.01 - $68.74 $9.09 Million - $13.6 Million	-197,517 Reduced 63.95%	111,335 $7.37 Million
Q3 2020 Nov 16, 2020	SELL	$41.91 - $57.81 $11.3 Million - $15.6 Million	-269,723 Reduced 46.62%	308,852 $14 Million
Q2 2020 Aug 14, 2020	SELL	$39.87 - $56.9 $10.9 Million - $15.5 Million	-272,692 Reduced 32.03%	578,575 $27.8 Million
Q1 2020 May 15, 2020	BUY	$34.22 - $76.49 $26.8 Million - $59.8 Million	781,721 Added 1124.03%	851,267 $38.5 Million
Q4 2019 Feb 14, 2020	SELL	$68.92 - $85.27 $28.3 Million - $35.1 Million	-411,239 Reduced 85.53%	69,546 $5.25 Million
Q3 2019 Nov 14, 2019	SELL	$71.74 - $86.35 $6.45 Million - $7.76 Million	-89,875 Reduced 15.75%	480,785 $35.5 Million
Q2 2019 Aug 14, 2019	BUY	$66.45 - $97.36 $33.8 Million - $49.5 Million	508,840 Added 823.1%	570,660 $41.1 Million
Q1 2019 May 15, 2019	BUY	$86.15 - $100.49 $4.8 Million - $5.6 Million	55,713 Added 912.28%	61,820 $0
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $8.24 Million - $12.3 Million	-97,979 Reduced 94.13%	6,107 $558,000
Q3 2018 Nov 13, 2018	BUY	$101.02 - $130.95 $1.77 Million - $2.29 Million	17,503 Added 20.22%	104,086 $0
Q2 2018 Aug 10, 2018	SELL	$81.75 - $105.37 $258,411 - $333,074	-3,161 Reduced 3.52%	86,583 $0
Q1 2018 May 11, 2018	SELL	$79.95 - $89.74 $3.84 Million - $4.31 Million	-48,016 Reduced 34.85%	89,744 $7.94 Million
Q4 2017 Feb 09, 2018	BUY	$71.8 - $88.21 $3.02 Million - $3.71 Million	42,081 Added 43.98%	137,760 $11 Million
Q3 2017 Nov 09, 2017	BUY	$60.32 - $70.06 $5.77 Million - $6.7 Million	95,679	95,679 $6.7 Million

Others Institutions Holding LIVN

# of Institutions

256

Shares Held

55.9M

Call Options Held

566K

Put Options Held

506K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.62B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account